Guest guest Posted August 20, 2007 Report Share Posted August 20, 2007 http://www.telegraph.co.uk/money/main.jhtml?xml=/money/2007/08/20/cneli120.xml & D\ CMP=ILC-traffdrv07053100 Eli Lilly turns to Chi-Med By Mark Kleinman in Hong Kong 20/08/2007 Eli Lilly, the global pharmaceuticals giant behind blockbuster drugs including the anti-depressant Prozac, is turning to ancient Chinese remedies for a new pipeline of treatments. The partnership may help improve the image of Chinese medicines in the West Hutchison China Meditech (Chi-Med), the AIM-listed subsidiary of Hong Kong conglomerate Hutchison Whampoa, will announce today that it has struck a drug discovery and development partnership with Eli Lilly, which is based in New York. The tie-up will see Hutchison Medipharma, Chi-Med's research and development arm, paid up to $29m in so-called " milestone fees " for each drug candidate developed from the company's vast collection of herbal compounds. Chi-Med will also gain an undisclosed up-front payment and annual research and development fees from its US partner. Dr William Chin, vice-president of discovery research and clinical investigation for Eli Lilly, said: " We are excited to explore this innovative research collaboration model. " The agreement will initially focus on developing treatments in the areas of oncology and inflammation, with Chi-Med responsible for identifying candidates for clinical trial and Eli Lilly providing technical advice and subsequent development activities. For Chi-Med, the partnership may provide a much-needed boost to its beleaguered share price and help improve the image of Chinese medicines in the West. advertisement The company, which listed its shares at 275p when it floated on AIM last year, has seen its stock price drift steadily downward despite announcing deals with Merck, the German pharmaceuticals firm, and Procter & Gamble, a partnership that involves P & G developing health and beauty products from Chi-Med compounds. Hutchison Whampoa, which is chaired by Li Ka-shing, Asia's richest man, retains a 72pc stake in Chi-Med. Chi-Med's share price failed to move significantly even after announcing positive results from Phase-II trials of a treatment for ulcerative colitis and Crohn's disease earlier this year. News of the deal with Eli Lilly comes as China's pharmaceuticals industry is battling to rescue its reputation in the wake of a series of incidents which have exposed a large quantity of counterfeit medicines being exported from China. Today's announcement is also expected to point to the benefits of conducting drug R & D in China, where multinational firms are able to leverage the country's low cost-base and a growing contingent of qualified scientists. copyright of Telegraph Media Group Limited Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 21, 2007 Report Share Posted August 21, 2007 Chinese Traditional Medicine , dar <dobbie606 wrote: > > http://www.telegraph.co.uk/money/main.jhtml? xml=/money/2007/08/20/cneli120.xml & DCMP=ILC-traffdrv07053100 > > Eli Lilly, the global pharmaceuticals giant behind > blockbuster drugs including the anti-depressant > Prozac, is turning to ancient Chinese remedies for a > new pipeline of treatments. > The partnership may help improve the image of Chinese > medicines in the West Or worsen it as the case may be. > The tie-up will see Hutchison Medipharma, Chi-Med's > research and development arm, paid up to $29m in > so-called " milestone fees " for each drug candidate > developed from the company's vast collection of herbal > compounds. Chi-Med will also gain an undisclosed > up-front payment and annual research and development > fees from its US partner. These people simply do not get it. What makes something TCM is not that an herb is grown in China but the way it is used. Using an herb (or a food or a prescription drug or supplements or needles or whatever) within a TCM framework is what makes something TCM. Above all else TCM takes a holistic view of healing. How everything works (or doesn't work) together. The moment companies start isolating what they consider to be " active ingredients " in order to treat one specific symptom or illness, it ceases to be TCM. Some of the so-called inert or not significant ingredients often turn out to be something that is important. Allopathic medicine (and businesses) in the West have a long history of thinking they know more than they do. One of the best examples is the dicovery of and manufacturing of synthetic vitamin C. Vitamin C did not work as well as researchers originally had predicted. As it turned out, some of the effects of natural vitamin C were not coming from vitamin C but from compounds called bioflavanoids which occur with vitamin C when the vitamin is obtained from natural sources. Western research also rarely considers cases where compounds work together, prefering instead to concentrate on identifying and testing one particular chemical at a time. The exception to this has been in the field of research into vitamins and minerals - though said realizations usually came years and even decades after the discovery of the role of the vitamin or mineral in good health. A prime example is that oral administration of vitamin B12 is useless in treating prenicious anemia because people with this condition lack something called " instrinsic factor " which is needed to absorb vitamin B12. Another example is that the body needs calcium in order to be able to absorb magnesium and vice versa (though after this point is reached the two are in competition with each other). Another example is how vitamin C improves the absorption of iron. Etc. All these things were discovered years after the original discoveries. In contrast TCM takes it as a given that things work together holistically. Another problem with isolating compounds from herbs is that it ignores contraindications. It ignores balance. Under every single herbal entry in the Chinese Materia Medica (list of healing substances), one will see a section on cautions and contraindications. For example, Yang Tonic herbs can worsen Yin Deficiency and vice versa. Qi Tonic herbs given to a person who also has Qi Stagnation problems can worsen the Stagnation problems. Etc. Finally, this mass market approach ignores something that is very critical to TCM: What TCM treats are TCM imbalances, not allopathic- defined medical conditions. One of the biggest surprises about TCM to many Westerners is that the same allopathic-defined medical condition can have one or more of several possible TCM imbalances underlying it. For example, what helps one asthmatic may do nothing for a second and can even worsen the asthma of a third because the TCM " Roots " are different. What these pharmaceutical companies are doing is NOT TCM. It's the same old same old approach that in the West not only has reached the point of diminishing returns but of hurting more and more people. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 21, 2007 Report Share Posted August 21, 2007 Victoria, I was thinking the same thing as I read that article... this is not limited to TCM, there is a push from these drug companies to muscle in on the alternative medicine " market " by using their powerful political influence with oversight agencies to come up with " regulation " aimed at forcing smaller companies, who haven't got the financial resources or regulatory experience, to either go under or form alliances with them in order to survive! If you ask me, I see nothing being able to stop them from taking over! Money moves everything in the world these days and it behooves each of us to do everything we can on a personal basis to maintain health by life style and other means of cultivation rather than looking for correct imbalances after they occur, after all, they cannot regulate that... yet! Domingo victoria_dragon wrote: > > Chinese Traditional Medicine > <Chinese Traditional Medicine%40>, dar <dobbie606 wrote: > > > > http://www.telegraph.co.uk/money/main.jhtml? > <http://www.telegraph.co.uk/money/main.jhtml?> > xml=/money/2007/08/20/cneli120.xml & DCMP=ILC-traffdrv07053100 > > > > Eli Lilly, the global pharmaceuticals giant behind > > blockbuster drugs including the anti-depressant > > Prozac, is turning to ancient Chinese remedies for a > > new pipeline of treatments. > > The partnership may help improve the image of Chinese > > medicines in the West > > Or worsen it as the case may be. > > > The tie-up will see Hutchison Medipharma, Chi-Med's > > research and development arm, paid up to $29m in > > so-called " milestone fees " for each drug candidate > > developed from the company's vast collection of herbal > > compounds. Chi-Med will also gain an undisclosed > > up-front payment and annual research and development > > fees from its US partner. > > These people simply do not get it. What makes something TCM is not > that an herb is grown in China but the way it is used. Using an herb > (or a food or a prescription drug or supplements or needles or > whatever) within a TCM framework is what makes something TCM. > > Above all else TCM takes a holistic view of healing. How everything > works (or doesn't work) together. The moment companies start > isolating what they consider to be " active ingredients " in order to > treat one specific symptom or illness, it ceases to be TCM. Some of > the so-called inert or not significant ingredients often turn out to > be something that is important. > > Allopathic medicine (and businesses) in the West have a long history > of thinking they know more than they do. One of the best examples is > the dicovery of and manufacturing of synthetic vitamin C. Vitamin C > did not work as well as researchers originally had predicted. As it > turned out, some of the effects of natural vitamin C were not coming > from vitamin C but from compounds called bioflavanoids which occur > with vitamin C when the vitamin is obtained from natural sources. > > Western research also rarely considers cases where compounds work > together, prefering instead to concentrate on identifying and testing > one particular chemical at a time. The exception to this has been in > the field of research into vitamins and minerals - though said > realizations usually came years and even decades after the discovery > of the role of the vitamin or mineral in good health. A prime example > is that oral administration of vitamin B12 is useless in treating > prenicious anemia because people with this condition lack something > called " instrinsic factor " which is needed to absorb vitamin B12. > Another example is that the body needs calcium in order to be able to > absorb magnesium and vice versa (though after this point is reached > the two are in competition with each other). Another example is how > vitamin C improves the absorption of iron. Etc. > > All these things were discovered years after the original > discoveries. In contrast TCM takes it as a given that things work > together holistically. > > Another problem with isolating compounds from herbs is that it > ignores contraindications. It ignores balance. Under every single > herbal entry in the Chinese Materia Medica (list of healing > substances), one will see a section on cautions and > contraindications. For example, Yang Tonic herbs can worsen Yin > Deficiency and vice versa. Qi Tonic herbs given to a person who also > has Qi Stagnation problems can worsen the Stagnation problems. Etc. > > Finally, this mass market approach ignores something that is very > critical to TCM: What TCM treats are TCM imbalances, not allopathic- > defined medical conditions. One of the biggest surprises about TCM > to many Westerners is that the same allopathic-defined medical > condition can have one or more of several possible TCM imbalances > underlying it. For example, what helps one asthmatic may do nothing > for a second and can even worsen the asthma of a third because the > TCM " Roots " are different. > > What these pharmaceutical companies are doing is NOT TCM. It's the > same old same old approach that in the West not only has reached the > point of diminishing returns but of hurting more and more people. > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2007 Report Share Posted August 22, 2007 Chinese Traditional Medicine , Domingo Pichardo <dpichardo3 wrote: > If you ask me, I see nothing being able to stop them from taking over! > Money moves everything in the world these days and it behooves each of > us to do everything we can on a personal basis to maintain health by > life style and other means of cultivation rather than looking for > correct imbalances after they occur, after all, they cannot regulate > that... yet! The only thing I know of that can stop them is to get the word out to as many people as one can that this is NOT TCM and that people are being shortchanged and even denied real TCM help by this being passed off as being related to TCM. Getting the word out is slow, but I can't think of any other way to stop this misuse and misinformation. Victoria Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 23, 2007 Report Share Posted August 23, 2007 Re: Eli Lilly buys out TCM --- In Chinese Traditional Medicine , " victoria_dragon " wrote: The only thing I know of that can stop them is to get the word out to as many people as one can that this is NOT TCM and that people are being shortchanged and even denied real TCM help by this being passed off as being related to TCM. Getting the word out is slow, but I can't think of any other way to stop this misuse and misinformation. Victoria ---- G'day TCMers, -Rbt Cohen tries valiantly to awaken the slumbering masses & now Dr.Victoria has urged us to join the fray. Alas, we may not be able to do this for long.It seems implants are much more insidious than we can imagine: http://www.us-government-torture.com/ cheers, dar One Reason For My Continuing Insanity by Robert Cohen I have not previously written about this factor... it is giving me nightmares. In 1990, I helped a 60 Minutes producer (Isadore Roesemarin) do a segment on aspartame/NutraSwee t, the artificial sweetener. When Searle Pharmaceuticals got NutraPoison approved, their president was a man by the name of Donald Rumsfeld. They then sold the company to Monsanto. A 30-year-old named Clarence Thomas was then Monsanto's lawyer. A congressman by the name of John Ashcroft had received the greatest number of political donations from Monsanto. That's just a bit of trivia and not the primary point to be made here... At that time I carefully went through Searle's research. They had submitted 112 studies to the FDA for approval. The FDA designated 17 of those studies to be " pivotal. " By naming a study " pivital " it had to be available to the public in its entirety. So...I filed a Freedom of Information Act request for the 17 studies. One of them was performed at the University of Wisconsin on Rhesus Monkeys. After day 300 of that one-year study every single one of the monkeys (low dose, medium dose, and high dose groups) developed grand mal epileptic seizures. Although I totally reject animal research, I recognize that the performance and review of such research is THEIR game. THEY set the criteria. When lab animals suffer adverse affects, THEY are responsible for telling the truth. In this case, THEY ignored the truth. I discovered the truth. One month before the report aired, I met with a man by the name of Michael Friedman, a high level FDA bureaucrat. I shared the results of the study with him. FDA had approved aspartame by concluding that there were no adverse affects on laboratory animals. I found that FDA had erred. Friedman had my information. I also found an ex-FDA employee willing to testify regarding internal FDA pressures to ignore the facts and approve NutraSweet. There was fraud and deceit at FDA. The public was about to be intentionally poisoned. When the actual 60 Minutes piece aired, they left the testimony of the FDA employee on the cutting room floor. Furthermore, Friedman, armed with my information, was interviewed and said, " There were no adverse affects on lab animals. " He lied and I was angry and disappointed. The man represented pure evil to me. Three months later he was named FDA Commissioner. Six months after that he left FDA to become the new president of the NutraSweet company. Now, I get to the real point of my story. While I was addicted to Oxycontin, the FDA fined the manufacturer, Purdue Pharmaceuticals, $634 million for deceptive practices... for not revealing that Oxycontin was more addictive than heroin. This week after weaning myself from this powerful drug, I learned that the acting president of that company is the very same Michael Friedman. I live in a world of conspiracy theories, and I do too much research for my own good. The paper trails seem impossible for investigative reporters to follow, while they are marked with day-glo paint for me. Call it my curse. I do what I do for the public, I guess. I keep no secrets. I immediately write about them. Perhaps, in a conspiracy theory world, that is what keeps me alive. I do not really give a damn any more about my safety. Their crimes against mankind are so serious that I must do what I do. My Woodstock generation.. .we were going to change the world, remember? Remember our phony ideals and how everybody we know sold out and became our own parents? Am I just wasting my time? Robert Cohen i4crob (AT) earthlink (DOT) net www.notmilk.com Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.